Sales · healthcare · LATAMJul 202611 min read355 words

The sales enablement framework we install for every client for healthcare and life sciences in Latin America

A repeatable, seven-part framework for running sales enablement as a system — the same one we use inside every Growth Broker engagement. Written for commercial leaders at healthtech, medtech, and life-sciences companies in Latin America.

This edition of the Growth Broker playbook is written for commercial leaders at healthtech, medtech, and life-sciences companies operating in Latin America. In this market, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms, so the way you install sales enablement has to be shaped to that reality from day one.

We have installed sales enablement inside more than fifty companies. This is the framework we reach for every time. Sales enablement is putting the exact asset a rep needs in front of the exact deal at the exact stage, and the framework exists to keep that definition honest under real conditions.

Part one, diagnosis. Before you touch the model, name the constraint: finance, demand, access, or conversion. Sales enablement applied to the wrong constraint is theatre.

Part two, target. Narrow to one industry, one role, one trigger. Every extra dimension halves conversion.

Inside healthcare and life sciences, the binding constraint is almost always regulated-sale cycle length, not intent, and in Latin America it is compounded by the fact that local partnership depth, not marketing spend is what actually gates growth. Sales enablement is only useful here when it is pointed at both constraints at once.

Part three, offer. What is the buyer's next step, and what makes it obvious? The offer, not the copy, is what carries.

Part four, engine. Tools, sequences, data. Buy the minimum you can operate; every extra tool is a future dependency.

Part five, operating rhythm. Monday plan, Friday review, weekly ramp time for new reps to first closed-won. Nothing about the model is left to memory.

Parts six and seven, learning and allocation. What did we learn last week; where does next week's dollar go. Once those two loops are live, sales enablement compounds and the framework stops being visible.

Concretely for healthcare and life sciences in Latin America: the healthcare teams that install this get past procurement instead of dying in it, and one properly-installed LATAM account becomes a reference across the region. That is the reason it is worth installing sales enablement deliberately for this market rather than importing a playbook designed for somewhere else.

sales enablementsales collateralbattle cardssales enablement frameworksales enablement modelsales enablement for healthcare and life sciencessales enablement in Latin Americahealthcare and life sciences growth in Latin America

Frequently asked questions

Sales · healthcare · LATAM — answered

Does sales enablement work for healthcare and life sciences in Latin America?
Yes — provided it is pointed at regulated-sale cycle length, not intent and adapted to the fact that in Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms. The healthcare teams that install this get past procurement instead of dying in it.
Do I need all seven parts to see results?
Diagnosis, target, and operating rhythm are the non-negotiables. The others can lag by weeks, not quarters.
How long does the framework take to install?
Six to twelve weeks depending on the state of the data and the size of the team.
Can I adapt the framework to my stack?
The framework is stack-agnostic. Tooling is part four and is the most swappable piece.
What is the biggest risk to the framework?
Content libraries no one opens — usually because a stakeholder shortcuts diagnosis to get to spend.
What is the LATAM-specific pitfall when running sales enablement for healthcare?
Importing a playbook that was built for another market. In Latin America, LATAM buyers reward hands-on partnership, local presence, and clear commercial terms — the install has to reflect that.

Growth Broker editorial

Filed under sales · healthcare · latam

Up next

AI for Growth: the complete 2026 guide for B2B companies

Read piece

Ready to broker your growth?

Book a Growth Call